Pfizer applies to register Covid-19 vaccine in Brazil

This is the second vaccine submitted for registration in Brazil. AstraZeneca Plc applied for full regulatory approval on Jan. 29 for the vaccine it developed with Oxford University.

Brazilian health regulator Anvisa said on Saturday that Pfizer Inc has applied for full regulatory approval of its COVID-19 vaccine developed with BioNTech Se.

A vial and syringe are seen in front of a displayed Pfizer and Biontech logo in this illustration taken January 11, 2021. (REUTERS)

This is the second vaccine submitted for registration in Brazil. AstraZeneca Plc applied for full regulatory approval on Jan. 29 for the vaccine it developed with Oxford University.

It will be made in Brazil in partnership with the federally funded Fiocruz biomedical center.